TherapeuticsMD, Inc. (NYSE:TXMD – Get Rating)’s share price fell 2.5% on Friday . The company traded as low as $3.50 and last traded at $3.56. 20,337 shares traded hands during trading, a decline of 50% from the average session volume of 40,933 shares. The stock had previously closed at $3.65.
Analyst Ratings Changes
Separately, StockNews.com started coverage on TherapeuticsMD in a research report on Thursday, March 16th. They issued a “hold” rating for the company.
TherapeuticsMD Price Performance
The firm has a market cap of $33.55 million, a P/E ratio of -2.49 and a beta of 1.17.
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm’s technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes.
Further Reading
- Get a free copy of the StockNews.com research report on TherapeuticsMD (TXMD)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
